BGICC25 Updates: Dr. Frédérique Penault-Llorca on AI in Pathology and Cancer Diagnostics
The 17th BGICC (Breast Gynecological and Immunooncology International Cancer Conference) was held on 23rd-24th January 2025 at the Hilton Heliopolis Hotel in Cairo, Egypt. This conference, recognized as the largest and most prestigious cancer event in Africa and the Middle East, served as a major platform for discussing the latest updates and trends in breast and gynecological cancers.
Under the slogan “Illumination and Creation,” it also highlighted advancements in genetics and immuno-oncology, covering all oncology aspects from diagnosis to future innovations. The event featured a range of scientific and educational symposia, workshops, debates, and recommendation sessions, with collaborations from world-renowned scientists and esteemed societies.
Dr. Frédérique Penault-Llorca, a pathologist and molecular pathologist from Clermont-Ferrand, France, joins OncoDaily to discuss the role of artificial intelligence in pathology. She explores how AI-based tools assist in breast cancer subtype recognition, mitosis counting, and biomarker evaluation while emphasizing the need for validation and human oversight. Dr. Penault-Llorca highlights the irreplaceable role of pathologists in ensuring accurate diagnoses and correlating findings with clinical data.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023